Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Al-Janazreh%2C+Hamdi%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Al-Janazreh%2C+Hamdi%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Al-Janazreh%2C+Hamdi%22&type=Person&sort=year
PubPharm (12)
1
Radiation induced delayed transverse myelitis and neurological deficit at tertiary care center
enthalten in:
Annals of medicine and surgery (2012)
| 2021
von
Abuzneid, Y.
|
Al-Janazreh, H.
|
Haif, M.
| +5
Wird geladen...
2
An unusual case of T-cell acute lymphoblastic leukemia in a patient with BCR-ABL positive chronic myeloid leukemia and Gaucher disease
enthalten in:
Annals of medicine and surgery (2012)
| 2021
von
Al-Janazreh, H.
|
Abuzneid, Y.
|
Khamayseh, I.
| +5
Wird geladen...
3
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine : Results of study on 486 cases outside clinical trials
enthalten in:
American journal of hematology
| 2021
von
Morabito, F.
|
Tripepi, G.
|
Del Poeta, G.
| +46
Wird geladen...
4
TP53 disruption as a risk factor in the era of targeted therapies : A multicenter retrospective study of 525 chronic lymphocytic leukemia cases
enthalten in:
American journal of hematology
| 2021
von
Morabito, F.
|
Del Poeta, G.
|
Mauro, F.
| +45
Wird geladen...
5
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases
enthalten in:
European journal of haematology
| 2021
von
Morabito, F.
|
Tripepi, G.
|
Del Poeta, G.
| +47
Wird geladen...
6
Spotlight on Melphalan Flufenamide : An Up-and-Coming Therapy for the Treatment of Myeloma
enthalten in:
Drug design, development and therapy
| 2021
von
Morabito, F.
|
Tripepi, G.
|
Martino, E.
| +11
Wird geladen...
7
Effectiveness of ibrutinib as first‐line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab‐bendamustine : Results of study on 486 cases outside clinical trials
enthalten in:
American Journal of Hematology
| 2021
von
Morabito, F.
|
Tripepi, G.
|
Del Poeta, G.
| +46
Wird geladen...
8
TP53 disruption as a risk factor in the era of targeted therapies : A multicenter retrospective study of 525 chronic lymphocytic leukemia cases
enthalten in:
American Journal of Hematology
| 2021
von
Morabito, F.
|
Del Poeta, G.
|
Mauro, F.
| +45
Wird geladen...
9
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib-rituximab
enthalten in:
Blood cancer journal
| 2020
von
Gentile, M.
|
Martino, E.
|
Visentin, A.
| +37
Wird geladen...
10
TP53 dysfunction in chronic lymphocytic leukemia : clinical relevance in the era of B-cell receptors and BCL-2 inhibitors
enthalten in:
Expert opinion on investigational drugs
| 2020
von
Morabito, F.
|
Gentile, M.
|
Monti, P.
| +19
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
12
Aufsätze
12
E-Artikel
12
E-Ressourcen
Zeitschriftentitel
2
American Journal of Hematology
2
American journal of hematology
2
Annals of medicine and surgery (2012)
2
Expert opinion on investigational drugs
1
Blood cancer journal
1
Drug design, development and therapy
1
European journal of haematology
1
Expert opinion on pharmacotherapy
Alle anzeigen ...
weniger ...
Thema
4
Journal Article
4
ibrutinib
4
idelalisib
3
4F4X42SYQ6
3
Research Support, Non-U.S. Gov't
3
Review
3
Rituximab
3
therapy
2
1X70OSD4VX
2
Adenine
2
Antineoplastic Agents
2
BCL2 inhibitor
2
BCR inhibitors
2
CML
2
Case Reports
2
Case report
2
JAC85A2161
2
Letter
2
Piperidines
2
Purines
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
8
2021
4
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
10
Englisch
Haven't found what you're looking for?
Wird geladen...